drugset / Trial / NCT01062971

Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

NCT01062971

Phase 2 Completed 124 enrolled Laboratorios Sophia S.A de C.V.
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare intraocular pressure lowering effectiveness of a new fixed combination drug.

Timeline

Start
2006-02
Primary completion
2007-08
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule 0.2 % Other
Comparator Dorzolamide Small molecule 2 % Other
Comparator Timolol Other / unclassified 0.5 % Other